HER-2 expression is correlated with multimodal imaging features in breast cancer: a pilot study

Objective A pilot study to evaluate the correlation between multimodal imaging features and the expression of the human epidermal growth factor receptor type 2 (HER-2) in breast cancer to provide a basis for clinical treatment and prognosis evaluation.